- Home
- ELS vs EXAS Comparison
ELS vs EXAS Comparison
Compare ELS & EXAS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ELS
- EXAS
- Stock Information
- Founded
- ELS 1992
- EXAS 1995
- Country
- ELS United States
- EXAS United States
- Employees
- ELS N/A
- EXAS N/A
- Industry
- ELS Real Estate Investment Trusts
- EXAS Medical Specialities
- Sector
- ELS Real Estate
- EXAS Health Care
- Exchange
- ELS Nasdaq
- EXAS Nasdaq
- Market Cap
- ELS 12.0B
- EXAS 11.0B
- IPO Year
- ELS 1993
- EXAS N/A
- Fundamental
- Price
- ELS $63.11
- EXAS $67.47
- Analyst Decision
- ELS Buy
- EXAS Strong Buy
- Analyst Count
- ELS 11
- EXAS 18
- Target Price
- ELS $70.86
- EXAS $72.44
- AVG Volume (30 Days)
- ELS 2.2M
- EXAS 2.9M
- Earning Date
- ELS 10-22-2025
- EXAS 11-03-2025
- Dividend Yield
- ELS 3.27%
- EXAS N/A
- EPS Growth
- ELS 2.36
- EXAS N/A
- EPS
- ELS 1.99
- EXAS N/A
- Revenue
- ELS $1,535,911,000.00
- EXAS $3,082,033,000.00
- Revenue This Year
- ELS $1.15
- EXAS $16.68
- Revenue Next Year
- ELS $4.52
- EXAS $12.36
- P/E Ratio
- ELS $31.63
- EXAS N/A
- Revenue Growth
- ELS 0.93
- EXAS 14.47
- 52 Week Low
- ELS $58.15
- EXAS $38.81
- 52 Week High
- ELS $73.67
- EXAS $72.81
- Technical
- Relative Strength Index (RSI)
- ELS 60.86
- EXAS 66.59
- Support Level
- ELS $60.36
- EXAS $64.92
- Resistance Level
- ELS $61.24
- EXAS $72.81
- Average True Range (ATR)
- ELS 1.18
- EXAS 2.17
- MACD
- ELS 0.13
- EXAS -0.13
- Stochastic Oscillator
- ELS 99.17
- EXAS 48.27
About ELS Equity Lifestyle Properties Inc.
Equity Lifestyle Properties is a residential REIT that focuses on owning manufactured housing, residential vehicle communities, and marinas. The company currently has a portfolio of 455 properties across the U.S. with a higher concentration in the Sunbelt region with 38% of the company's properties located in Florida, 12% in Arizona, and 8% in California. Equity Lifestyle targets owning properties in attractive retirement destinations with over 70% of the company's properties either being age-restricted or having an average resident age over 55.
About EXAS Exact Sciences Corporation
Exact Sciences, headquartered in Madison, Wisconsin, provides cancer screening and diagnostic test products in the United States and internationally. Exact's Cologuard screening test is a noninvasive stool-based DNA test for colorectal cancer. The company also competes in the precision oncology market with Oncotype DX, a suite of tissue-based genomic tests for estimating recurrence risk and likelihood of benefit from chemotherapy for breast and colon cancer, and OncoExTra, a liquid-based comprehensive genomic profiling test. It also has a pipeline of blood-based tests for molecular residual disease, colorectal cancer screening, and multicancer screening.